AstraZeneca Koselugo gets Chinese nod for paediatric patients with neurofibromatosis type 1, plexiform neurofibromas Ruchika Sharma9 May 2023 12:30 PM ISTIn addition to China, Koselugo is also approved in the US, EU, Japan and several other countries for the treatment of paediatric patients with NF1 and...
Selumetinib safe option for treatment of inoperable plexiform neurofibromas Medical Dialogues Editorial Team7 Jun 2022 12:15 PM ISTSelumetinib is a medication that is both effective and safe for young patients having symptomatic, inoperable plexiform neurofibromas, says an article...
selumetinib effective, safe in kids with symptomatic and inoperable plexiform neurofibromas Dr. Shravani Dali9 April 2022 10:00 AM ISTSelumetinib is effective and safe in children with symptomatic and inoperable plexiform neurofibromas (PN), according to a recent study published in...
FDA approves first treatment for Neurofibromatosis in children Dr. Kamal Kant Kohli11 April 2020 7:08 AM ISTThe U.S. Food and Drug Administration has approved Koselugo (selumetinib) for the treatment of pediatric patients, 2 years of age and older, with...
